EUVIMEDEUVIMED entdecken
Crossref

Predicting flow cytometry crossmatch results from single‐antigen bead testing

Patrick A Flynn iD, Sebastian Fernando, Judith E Worthington, Kay V Poulton iD

International Journal of Immunogenetics · 2024-04 · 51 (2) · 93-99

DOI: 10.1111/iji.12658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Immunogenetics, online erschienen am 19.02.2024. Verfasst von Patrick A Flynn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Transplantation Laboratory, Manchester Royal Infirmary, Manchester, UK. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to devise an algorithm that would predict flow cytometry crossmatch (FCXM) results using single‐antigen bead (SAB) mean fluorescent intensity (MFI) levels using samples received through the National External Quality Assurance Scheme (NEQAS) 2B external proficiency testing scheme between 2019 and 2023. A total of 159 serum samples were retrospectively screened using LABScreen Single Antigen Class I and II (SAB), and 40 peripheral blood samples were human leucocyte antigen (HLA) typed with LABType SSO. Donor‐specific antibodies were identified for each cell–serum combination tested, and cumulative MFI values were calculated for each test before correlating the screening result with the consensus crossmatch results for this scheme. HLA Class I MFIs were combined to predict the T cell crossmatch. For the B cell crossmatch prediction, two options were considered: (i) HLA Class II MFI values alone and (ii) HLA Class I + Class II MFIs. Receiver operating characteristic analysis was carried out to identify the combined MFI threshold that predicted NEQAS consensus results with the greatest sensitivity and specificity. HLA Class I combined MFI >5000 predicted T cell crossmatch results with 96% sensitivity, 100% specificity, 100% positive predictive value (PPV) and 92% negative predictive value (NPV). For B cell results, HLA Class I + Class II combined MFIs >11,000 gave the best model, showing 97% sensitivity, 82% specificity, 96% PPV and 85% NPV. However, for samples with only HLA Class II sensitization, combined MFIs >13,000 improved the B cell crossmatch predictions: 92% sensitivity, 95% specificity, 96% PPV and 91% NPV. Using this model, combined MFI can be used to predict the immunological risk posed by donor‐specific antibodies when it is not possible to carry out an FCXM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHumansFlow CytometryRetrospective StudiesHistocompatibility TestingAntibodiesHLA AntigensIsoantibodiesGraft Rejection

Stichwörter der Autor:innen

HLAhistocompatibilityimmunogeneticstransplantation

Substanzen

AntibodiesHLA AntigensIsoantibodies

Autor:innen und Institutionen

  • Transplantation Laboratory, Manchester Royal Infirmary, Manchester, UK.
  • School of Health Education and Public Health Sciences.

ORCID-Profile: Patrick A Flynn, Kay V Poulton

Zitieren

APA

Flynn, P. A., Fernando, S., Worthington, J. E., & Poulton, K. V. (2024). Predicting flow cytometry crossmatch results from single‐antigen bead testing. International Journal of Immunogenetics, 51(2), 93-99. https://doi.org/10.1111/iji.12658

Vancouver

Flynn PA, Fernando S, Worthington JE, Poulton KV. Predicting flow cytometry crossmatch results from single‐antigen bead testing. International Journal of Immunogenetics. 2024;51(2):93-99. doi:10.1111/iji.12658

BibTeX
@article{Flynn2024,
  author = {Flynn, Patrick A and Fernando, Sebastian and Worthington, Judith E and Poulton, Kay V},
  title = {Predicting flow cytometry crossmatch results from single‐antigen bead testing},
  journal = {International Journal of Immunogenetics},
  year = {2024},
  volume = {51},
  number = {2},
  pages = {93--99},
  doi = {10.1111/iji.12658}
}
Kostenlos starten →